Ha Rim Shin

Ha Rim Shin

Auto-generated profile, based on publicly available information

Ha Rim Shin

Department of Health Sciences, The Graduate School of Dong-A University, 49315 Busan, Republic of Korea

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 August 2025 in Frontiers in Bioscience-Landmark
Verified
Journal Article
Open access
HSHa Rim Shin
Ha Rim Shin
GLGaheon Lee
Gaheon Lee
KKkyung kim
kyung kim
Mitochondria play crucial roles in maintaining health and influencing disease progression by acting as central regulators of cellular homeostasis and energy production. Dysfunctions in mitochondrial activity are increasingly recognized as key contributors to various pathologies, ultimately impacting healthspan and disease outcomes. However, traditional treatments often do not restore damaged mitochondria to a healthy state. Mitochondrial transplantation, a cellular organelle-based therapy in which mitochondria are introduced into a recipient, has emerged as a novel concept in next-generation therapeutics that overcomes the limitations of current cell-based treatments. This review highlights the unique properties of mitochondria as therapeutic agents, including their ability to restore cellular functions and treat a wide range of diseases. In this review, we focus on the unique role of mitochondria in the regulation of stem cell functions, including stem cell fate, self-renewal, and differentiation. Various perspectives have been explored to better understand mitochondrial transplantation therapy, which harnesses the capacity of mitochondria as living drugs in regenerative medicine, as an innovative strategy to bridge the gap between cell therapy and organelle-based treatments and overcome current clinical barriers.

30 September 2026 in Kosin Medical Journal
Verified
Journal Article
Open access
HSHa Rim Shin
Ha Rim Shin
Cellular metabolism actively shapes immune cell fate, function, and lineage commitment through coordinated metabolic reprogramming, rather than serving merely as a passive energy supply. Distinct metabolic pathways, including glycolysis, mitochondrial respiration, fatty acid oxidation, and amino acid catabolism, govern the functional polarization of innate and adaptive immune cells. Accordingly, immunometabolic dysregulation contributes to the pathogenesis of diverse human diseases, including cancer, metabolic disorders, autoimmune disorders, and infectious diseases. Targeting central nutrient-sensing pathways involving mechanistic target of rapamycin, adenosine monophosphate-activated protein kinase, hypoxia-inducible factor-1 alpha, and c-Myc may provide therapeutic avenues for restoring immune homeostasis. In parallel, single-cell multiomics, spatial metabolomics, and artificial intelligence-driven computational tools are defining immunometabolic heterogeneity with high resolution. This review summarizes the core principles of immunometabolism, describes cell-specific metabolic signatures, examines their roles in human disease, and outlines current therapeutic strategies and future directions for precision immunomodulation.